| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| An Equity Checklist: a Framework for Health Technology Assessments |
0 |
0 |
1 |
91 |
2 |
3 |
21 |
289 |
| Cost, context and decisions in Health Economics and cost-effectiveness analysis |
0 |
0 |
2 |
45 |
0 |
1 |
15 |
102 |
| Cost-containment in Europe |
0 |
0 |
0 |
190 |
0 |
0 |
11 |
712 |
| Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use |
0 |
0 |
0 |
89 |
2 |
2 |
19 |
355 |
| Deliberative Processes in Decisions about Health Care Technologies |
0 |
0 |
0 |
7 |
0 |
0 |
7 |
31 |
| Disability and Multi-Dimensional Quality of Life: A Capability Approach to Health Status Assessment |
0 |
0 |
1 |
69 |
1 |
1 |
13 |
64 |
| Does Cost-Effectiveness Analysis Discriminate against Patients with Short Life Expectancy? |
0 |
0 |
0 |
71 |
0 |
0 |
7 |
191 |
| Does cost-effectiveness analysis discriminate against patients with short life expectancy? Matters of logic and matters of context |
0 |
0 |
0 |
80 |
1 |
4 |
8 |
232 |
| Economics and public policy 0 NHS research and development as a public good |
0 |
0 |
1 |
24 |
0 |
0 |
7 |
150 |
| Efficiency, equity and equality in health and health care |
0 |
2 |
11 |
301 |
0 |
7 |
61 |
1,295 |
| Equality of what in health policy? Conflicts between the contenders |
0 |
0 |
6 |
248 |
1 |
4 |
22 |
650 |
| Evidence, Uncertainty and the Policy Pursuit of Fairness |
0 |
0 |
0 |
25 |
1 |
1 |
7 |
85 |
| Four decades of health economics through a bibliometric lens |
0 |
0 |
1 |
262 |
1 |
2 |
33 |
476 |
| Funding research in the NHS |
0 |
0 |
0 |
23 |
1 |
1 |
5 |
134 |
| Health service efficiency - appraising the appraisers |
0 |
0 |
0 |
36 |
0 |
1 |
4 |
142 |
| Health service ills: the wrong economic medicine (a critique of David Green's Which Doctor?) |
0 |
0 |
0 |
10 |
0 |
1 |
3 |
88 |
| Health, health expenditures and equity |
0 |
0 |
0 |
157 |
1 |
1 |
4 |
352 |
| Mark Pauly on Welfare Economics: Normative Rabbits from Positive Hats |
0 |
0 |
0 |
3 |
0 |
0 |
10 |
1,032 |
| Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions |
0 |
0 |
0 |
370 |
1 |
2 |
16 |
1,083 |
| NICE's Social Value Judgements about Equity in Health and Health Care |
0 |
0 |
0 |
55 |
1 |
1 |
6 |
153 |
| Need, equality and social justice |
0 |
0 |
2 |
240 |
2 |
2 |
9 |
1,599 |
| Need, equity and equality in health and health care |
0 |
0 |
4 |
880 |
3 |
6 |
34 |
2,680 |
| Parallel Lines do Intersect: Interactions between the Workers’ Compensation and Provincial Publicly Financed Health Care Systems in Canada |
0 |
0 |
0 |
17 |
0 |
0 |
7 |
160 |
| Parallel Payers and Preferred Access: How Canada's Workers' Compensation Boards Expedite Care for Injured and Ill Workers |
0 |
0 |
0 |
32 |
0 |
0 |
8 |
141 |
| Perspective in Economic Evaluations of Healthcare Interventions in Low- and Middle-Income Countries: One Size Does Not Fit All |
0 |
1 |
1 |
2 |
0 |
2 |
8 |
15 |
| QALYs versus HYEs - a theoretical exposition |
0 |
0 |
0 |
63 |
1 |
1 |
12 |
288 |
| The NICE Cost-Effectiveness Threshold: What it is and What that Means |
0 |
0 |
1 |
86 |
1 |
4 |
11 |
294 |
| The internal market: an acceptable means to a desirable end |
0 |
0 |
0 |
34 |
0 |
0 |
7 |
164 |
| Using cost-effectiveness analysis to address health equity concerns |
0 |
0 |
2 |
12 |
1 |
1 |
20 |
79 |
| Total Working Papers |
0 |
3 |
33 |
3,522 |
21 |
48 |
395 |
13,036 |
| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A Taxonomy of Demand Curves |
0 |
0 |
0 |
0 |
0 |
1 |
8 |
63 |
| A Utility-Maximising View of Universities |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
104 |
| A health economist on medical sociology: Reflections by an unreconstructed reductionist |
0 |
0 |
0 |
5 |
1 |
1 |
9 |
49 |
| Access, utilisation and equity: A further comment |
0 |
0 |
0 |
131 |
1 |
1 |
7 |
322 |
| An Equity Framework for Health Technology Assessments |
0 |
0 |
2 |
7 |
0 |
0 |
10 |
28 |
| Appraising Government Expenditure on Health Services: The Problems of "Need" and "Output." |
0 |
0 |
0 |
0 |
0 |
1 |
5 |
45 |
| Authors’ Reply to Angelis and Kanavos: “Does MCDA Trump CEA?” |
0 |
0 |
0 |
1 |
0 |
0 |
4 |
14 |
| CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? |
0 |
0 |
0 |
7 |
1 |
3 |
14 |
55 |
| Cost-effectiveness of foam elastomer and gauze dressings in the management of open perineal wounds |
0 |
0 |
0 |
7 |
0 |
1 |
6 |
79 |
| Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use |
0 |
1 |
2 |
20 |
1 |
3 |
18 |
128 |
| Cost-effectiveness thresholds: a comment on the commentaries |
0 |
0 |
0 |
2 |
1 |
1 |
4 |
27 |
| Cost‐effective public health guidance: asking questions from the decision‐maker's viewpoint |
0 |
0 |
0 |
58 |
1 |
2 |
10 |
226 |
| Disability and multidimensional quality of life: A capability approach to health status assessment |
0 |
0 |
0 |
12 |
0 |
0 |
21 |
124 |
| Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion |
0 |
0 |
0 |
88 |
0 |
0 |
7 |
309 |
| Discounting and decision making in the economic evaluation of health‐care technologies |
0 |
0 |
2 |
74 |
1 |
1 |
22 |
313 |
| Does MCDA Trump CEA? |
0 |
0 |
0 |
3 |
0 |
2 |
12 |
29 |
| Drugs and Pareto: a Methodological Abuse |
0 |
0 |
0 |
3 |
1 |
1 |
9 |
36 |
| Equity and equality in health and health care |
1 |
1 |
11 |
2,456 |
3 |
10 |
40 |
5,839 |
| Externality Models and Health:a Rückblick over the last Twenty Years |
0 |
0 |
0 |
7 |
1 |
2 |
11 |
30 |
| Four decades of health economics through a bibliometric lens |
0 |
1 |
4 |
98 |
0 |
2 |
28 |
418 |
| Health care and the market: A British lament |
0 |
0 |
0 |
23 |
0 |
0 |
1 |
59 |
| Health service efficiency: Appraising the appraisers--A critical review of economic appraisal in practice |
0 |
0 |
0 |
6 |
1 |
1 |
3 |
44 |
| Hic Sunt Dracones |
0 |
0 |
0 |
0 |
0 |
0 |
8 |
10 |
| How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations |
0 |
0 |
0 |
4 |
0 |
1 |
12 |
50 |
| How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States? |
0 |
0 |
0 |
4 |
0 |
2 |
11 |
51 |
| I. Should Social Policy Concern Itself with Drug “Abuse†? |
0 |
0 |
0 |
26 |
0 |
0 |
10 |
73 |
| JOINT PRODUCTS AND INTER‐JURISDICTIONAL SPILLOVERS: SOME PUBLIC GOODS GEOMETRY |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
6 |
| Joint Products and Multijurisdictional Spillovers |
0 |
0 |
0 |
13 |
0 |
0 |
5 |
83 |
| Letter from the editors |
0 |
0 |
0 |
6 |
0 |
0 |
4 |
45 |
| Mark Pauly on welfare economics: Normative rabbits from positive hats |
0 |
0 |
1 |
172 |
0 |
1 |
17 |
509 |
| Merit Goods and the Welfare Economics of Coercion |
0 |
0 |
0 |
0 |
0 |
1 |
19 |
127 |
| NICE's social value judgements about equity in health and health care |
0 |
0 |
0 |
20 |
0 |
1 |
11 |
118 |
| NICE's use of cost effectiveness as an exemplar of a deliberative process |
0 |
0 |
0 |
65 |
0 |
1 |
8 |
182 |
| Need: The idea won't do--But we still need it |
1 |
1 |
2 |
181 |
1 |
2 |
13 |
367 |
| ON THE RELATIVE EFFICIENCY OF THE NATIONAL HEALTH SERVICE* |
0 |
0 |
0 |
2 |
0 |
0 |
5 |
12 |
| Objectivity and Equity: Clarity Required. A Response to Hill and Olson |
0 |
0 |
0 |
2 |
0 |
1 |
4 |
28 |
| On the Economic Surplus and the Value of Life |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
164 |
| Organising Research and Development for evidence-informed health care: some universal characteristics and a case study from the UK |
0 |
0 |
0 |
1 |
0 |
1 |
1 |
4 |
| Pareto, Peacock and Rowley, and policy towards natural monopoly - comment |
0 |
0 |
0 |
13 |
0 |
0 |
5 |
125 |
| Preface |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
44 |
| Public or private health services? A Skeptic's view |
0 |
0 |
0 |
17 |
0 |
1 |
7 |
55 |
| QALYs versus HYEs |
0 |
0 |
0 |
47 |
0 |
3 |
12 |
180 |
| QALYs versus HYEs: A reply to Gafni, Birch and Mehrez |
0 |
0 |
0 |
33 |
0 |
0 |
3 |
158 |
| Some Inconsistencies in NICE’s Consideration of Social Values |
1 |
1 |
1 |
4 |
1 |
1 |
6 |
59 |
| The Nature of the Commodity 'Health Care' and Its Efficient Allocation |
0 |
0 |
1 |
391 |
1 |
4 |
14 |
950 |
| The Normative Economics of Health Care Finance and Provision |
0 |
0 |
0 |
3 |
3 |
6 |
23 |
1,409 |
| The bogus conflict between efficiency and vertical equity |
0 |
0 |
1 |
102 |
0 |
0 |
8 |
237 |
| The economics of non-proprietary organizations: Kenneth W. Clarkson and Donald L. Martin, eds. Research in Law and Economics, a Research Annual, Supplement I. Greenwich (Conn): JAI Press, 1980. xiii + 268 pp |
0 |
0 |
0 |
25 |
0 |
1 |
6 |
224 |
| The inequity of informal payments for health care: The case of Hungary |
0 |
1 |
1 |
46 |
0 |
2 |
10 |
143 |
| Utilisation as a measure of equity by Mooney, Hall, Donaldson and Gerard |
0 |
0 |
0 |
118 |
1 |
2 |
6 |
359 |
| We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment |
0 |
0 |
0 |
1 |
0 |
1 |
8 |
12 |
| Welfarism vs. extra-welfarism |
1 |
1 |
1 |
201 |
1 |
3 |
17 |
804 |
| Total Journal Articles |
4 |
7 |
29 |
4,507 |
21 |
69 |
510 |
14,929 |
LogEc is hosted by the
Örebro University School of Business.